Immunotherapy’s ‘Sweet’ Future: Wrapping up AACR IO 2025 With Glyco-immunology
The final day of AACR IO highlighted the emerging frontier of glyco-immunology.
Tag: AACR IO 2025
The final day of AACR IO highlighted the emerging frontier of glyco-immunology.
The third keynote session at AACR IO highlighted exciting advances in CAR T-cell therapy, including for solid cancers.
The second keynote session at AACR IO focused on deciphering T-cell receptors, creating TCR libraries, and rewiring cytokine signaling.
Immune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night...